Left bundle branch vs right ventricular pacing in AV-block and preserved LVEF post-TAVI (Phys-TAVI randomized trial)
Abstract Background There is currently no evidence of the best pacing mode for high-degree atrioventricular (AV) block occurring after transcatheter aortic valve implant (TAVI) in patients with preserved left ventricular systolic ejection fraction (LVEF). Purpose The purpose of the trial was to compare a clinical combined endpoint achieved by left bundle branch pacing (LBBP) vs right ventricular (RV) pacing in patients with preserved LVEF post-TAVI at 12-month follow-up. Methods Physiological vs right ventricular pacing in patients with normal ventricular function post-TAVI (Phys-TAVI) was a pilot study designed as a single-center, prospective, randomized, parallel-controlled clinical trial. Adhered to CONSORT guidelines. Consecutive patients (n=24) post-TAVI with high-degree AV block and LVEF≥50% were randomized to LBBP or RV pacing. The primary endpoint was survival with an improvement ≥1point in NYHA class or ≥25% increase in the distance covered in the 6-minute-walking-test (6MWT). Secondary endpoints were change in LVEF, septal flash correction, mitral regurgitation, NTproBNP, heart failure hospitalization, score on symptoms (KCCQ-12 Kansas City Cardiomyopathy Questionnaire), and QRS duration. Results Twenty-four patients were included, 12 in each arm. Median stimulation 98.6% (75%-99%), no differences between groups. Both groups showed a similar incidence of the primary endpoint: 33.3% (n=4) in LBBP group vs 25% (n=3) in RV group (p=1). One patient in each group had died at 1-year follow-up. In relation to secondary endpoints, significant shortening in the QRS was observed in LBBP patients, as compared to RV pacing (median -39ms vs 0ms), p<0.001. Septal flash excursion was significantly lower for the LBBP group (median 0mm vs 2mm), p=0.03. None of the patients had LVEF<50% at 12-month follow-up. Conclusion Similar midterm outcomes were obtained with LBBP and RV pacing in an elderly population with high-degree AV block and preserved LVEF after TAVI. The pilot Phys-TAVI trial showed the feasibility of LBBP in this population and set paves the way for larger randomized clinical trials with extended follow-up to test for differential clinical outcomes between pacing modalities.PhysTAVI trials results Endpoints Intention to treat analysis
Authors
- A Doltra
- Margarida Pujol‐López (ORCID: https://orcid.org/0000-0002-4523-6469)
- Eduard Guasch (ORCID: https://orcid.org/0000-0003-4238-5319)
- F R Graterol (ORCID: https://orcid.org/0009-0005-1898-7952)
- Ander Regueiro (ORCID: https://orcid.org/0000-0001-5201-447X)
- Ivo Roca‐Luque (ORCID: https://orcid.org/0000-0003-0731-3731)
- C Garcia-Ribas
- Lluı́s Mont (ORCID: https://orcid.org/0000-0002-8115-5906)
- Jean-Baptiste Guichard (ORCID: https://orcid.org/0000-0002-4696-7722)
- Andreu Porta‐Sánchez (ORCID: https://orcid.org/0000-0003-3510-1488)
- Roger Borràs (ORCID: https://orcid.org/0000-0002-8585-2522)
- L Uribe
- Elena Arbelo (ORCID: https://orcid.org/0000-0003-0424-6393)
- Mariona Regany‐Closa
- J M Tolosana
Institutions
- Hospital Clínic de Barcelona (ES)
- Consorci Institut D'Investigacions Biomediques August Pi I Sunyer (ES)
Publication Details
- Journal
- EP Europace
- Published
- 2025-05-01
- DOI
- https://doi.org/10.1093/europace/euaf085.545
- Primary Topic
- Cardiac pacing and defibrillation studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Instituto de Salud Carlos III
- European Social Fund